Freedom of Information Act Office
IC Directors' Meeting Highlights
December 10, 2004
|From:||Director, Executive Secretariat|
|Subject:||IC Directors Meeting Highlights—October 14, 2004|
I. EEO Restructuring Implementation Effort
Before beginning his formal presentation, Mr. Self announced that NIH has been awarded a certificate of recognition from OS for being the HHS OPDIV that placed the most students (eight) through the joint Federal Workforce Recruitment Program for students with disabilities. Because fully half of the NIH students placed were placed through NIAMS, Mr. Self passed on the kudos by presenting Dr. Katz with a certificate of appreciation for his outstanding efforts in this important Federal recruitment program.
Mr. Self explained that phase one of the NIH EEO restructuring took place on October 1, 2004, at which time all NIH EEO Staff were realigned into the OEODM with that Office assuming all payroll costs. Phase two has begun and will consist of a one-year transition period wherein Division staff will be selected, additional space will be acquired, and logistical and administrative issues will be addressed. He noted that OEODM will conduct evaluations of the new organization after 180 days and at the one-year mark to ensure the best quality program possible.
II. Update on Conflict of Interest Issues
Dr. Kington said that the NIH is working with the Office of the Secretary to develop interim supplementary regulations dealing with conflict of interest. Dr. Zerhouni stressed that this issue directly affects the public trust and thanked all for their continuing efforts.
III. Steering Committee Update
Dr. Kington summarized two recent steering committee meetings:
- one of which was an update on the Placement Program for Employees affected by the EASS MEO, and
- the other of which was a report on the status of the release of the 2003 Draft Update of the 1995 20-year Bethesda Campus Master Plan.
IV. Other Information Items
Dr. Zerhouni said that Public Access was drawing an immense amount of attention across the board from Congress, the media, professional and academic entities, scientists, and the publishing industry and that the NIH comment period would be open through November 16 for all constituencies to comment.
cc: OD Senior Staff